Many countries are taking strict measures to prevent the spread of COVID-19 with lockdowns, curfews, and closure of public spaces and services. As a result of stress and uncertainty caused by these strict measures, women and girls are at even greater risk of violence at a time when their access to s...ervices is further reduced. With many people’s livelihoods and incomes significantly affected, together with movement restrictions, basic hygiene and menstruation items are unlikely to be prioritised.
10 April, 2020
more
with special reference to prevention and control of avian influenza
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access for clarity. The publication of the RE...COVERY and REMAP-CAP randomised controlled trials triggered this guideline update, resulting in a strong recommendation for interleukin-6 (IL-6) receptor blockers (tocilizumab or sarilumab) in patients with severe or critical covid-19.
Prior recommendations: (a) A recommendation not to use ivermectin in patients with covid-19, regardless of disease severity, except in the context of a clinical trial; (b) a strong recommendation against the use of hydroxychloroquine in patients with covid-19, regardless of disease severity; (c) a strong recommendation against the use of lopinavir-ritonavir in patients with covid-19, regardless of disease severity; (d) a strong recommendation for systemic corticosteroids in patients with severe and critical covid-19; (e) a conditional recommendation against systemic corticosteroids in patients with non-severe covid-19; and (f) a conditional recommendation against remdesivir in hospitalised patients with covid-19.
more
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV‑2) causing coronavirus disease 2019 (COVID-19) has reached pandemic levels;
Patients with cardiovascular (CV) risk factors and established cardiovascular disease (CVD) represent a vulnerable population when suffering from COVID-19;
Patien...ts with cardiac injury in the context of COVID-19 have an increased risk of morbidity and mortality
more
The guide is designed to help disaster managers in national Governments gain basic knowledge of how to use international tools and services. It aims to support the growing disaster response and disaster response preparedness capabilities that exist at national level across Asia and the Pacific.
...
The guide is for national disaster management organizations (NDMOs) and line ministries involved in disaster response and disaster response preparedness. It is also a reference document for representatives of intergovernmental organizations, civilsociety actors and disaster-affected people.
The guide concentrates on key tools and services that can be helpful to disaster managers during the response and response preparedness phases of the disaster programme cycle.
more
The achievable imperative for global progress
Lessons from a decade of Progress
The Guide has been developed to enhance the knowledge capabilities of NDMAs and their local partners. This is accomplished by exposing them to the existing tools and services developed by the international community to facilitate effective disaster response to any scale of disaster (small, medium an...d large) and assist in comprehensive response preparedness
more
Nature Reviews Microbiology Vol. 17 (2019)pp.51-62
Antimicrobial susceptibility testing (AST) technologies help to accelerate the
initiation of targeted antimicrobial therapy for patients with infections and could potentially
extend the lifespan of current narrow- spectrum antimicrobials. Althoug...h conceptually new and
rapid AST technologies have been described, including new phenotyping methods, digital
imaging and genomic approaches, there is no single major, or broadly accepted, technological
breakthrough that leads the field of rapid AST platform development
more